Table 4. Genotype and plasma proline level of the PRODH deletion bearing patients.
ID | diagnosis | sex | age | plasma proline (μmol/L) | genotype | predicted PRODH residual activity |
---|---|---|---|---|---|---|
144.1 | SZAFF | F | 42 | 538 | DEL/R453C+ R185W | 2% |
144.2 | SZ | F | 39 | 338 | DEL/Q19P | 30% |
12 452 | Autism | M | 6 | 287 | DEL/R185W | 25% |
12 746 | HFA | F | 8 | 214 | DEL/Q19P+ A58T | ≤30% |
13 899 | Autism | M | 11 | 312 | DEL/Q19P | ≤25% |
44 737 | Autism | M | 7 | ND | DEL/T275N+ V427M | ≤20% |
45 435 | Autism | F | 31 | ND | DEL/R185W+ Q19P | ≤25% |
45 856 | Autism | M | 38 | ND | DEL/Q19P+ P30S | ≤30% |
46 261 | Autism | F | 11 | 243-283 | DEL/R185W+ Q19P | ≤25% |
47 766 | Autism | M | 8 | ND | DEL/WT | 50% |
Si30 | Autism | F | 5 | 422-1883 | DEL/R453C+ Q19P+ A58T + V427M | ≤2% |
12363 | MR | M | 11 | 512 | DEL/R185W | 25% |
11780 | MR | M | 3 | ND | DEL/R185W+ Q19P | ≤25% |
9680 | MR | F | 11 | 299 | DEL/Q19P+ P30S | ≤30% |
14684 | MR | M | 6 | 238 | DEL/R185W+ Q19P | ≤25% |
ND: not determined. WT: wild type. HFA: High-functioning autism